CLINICAL STUDIES
Changes in left ventricular filling and left atrial function six months after nonsurgical septal reduction therapy for hypertrophic obstructive cardiomyopathy
Sherif F. Nagueh, MD, FACCa,
Nasser M. Lakkis, MD, FACCa,
Katherine J. Middleton, RCTa,
Donna Killip, RNa,
William A. Zoghbi, MD, FACCa,
Miguel A. Quiñones, MD, FACCa and
William H. Spencer, III, MD, FACCa
a Cardiology Section, Department of Medicine, Baylor College of Medicine, Houston, Texas, USA
Manuscript received December 31, 1998;
revised manuscript received March 31, 1999,
accepted June 23, 1999.
Reprint requests and correspondence: Sherif F. Nagueh, Cardiology Section, Baylor College of Medicine, 6550 Fannin, SM1246, Houston, Texas 77030 sherifn{at}bcm.tmc.edu
OBJECTIVES
The purpose of this study was to evaluate changes in left ventricular (LV) filling, left atrial (LA) volumes and function six months after nonsurgical septal reduction therapy (NSRT) for hypertrophic obstructive cardiomyopathy (HOCM).
BACKGROUND
Patients with HOCM frequently have enlarged left atria, which predisposes them to atrial fibrillation. Nonsurgical septal reduction therapy results in significant reduction in left ventricular outflow tract (LVOT) obstruction and symptomatic improvement. However, its effect on LV passive filling volume, LA volumes and function is not yet known.
METHODS
Thirty patients with HOCM underwent treadmill exercise testing as well as 2-dimensional and Doppler echocardiography before and six months after NSRT. Data included clinical status, exercise duration, LVOT gradient, mitral regurgitant (MR) volume, LV pre-A pressure and LA volumes. Left atrial ejection force and kinetic energy (KE) were computed noninvasively and were compared with 12 age-matched, normal subjects.
RESULTS
New York Heart Association (NYHA) class was lower and exercise duration was longer (p < 0.05) six months after NSRT. The LVOT gradient, MR volume and LV pre-A pressure were all significantly reduced. HOCM patients had larger atria, which had a higher ejection force and KE, compared with normal subjects (p < 0.01). After NSRT, LV passive filling volume increased (p < 0.01), whereas LA volumes, ejection force and KE decreased (p < 0.01). Reduction in LA maximal volume was positively related to changes in LV pre-A pressure (r = 0.8, p < 0.05) and MR volume (0.4, p < 0.05). Changes in LA ejection force were positively related to changes in LA pre-A volume (r = 0.7, p < 0.01) and KE (r = 0.81, p < 0.01). The increase in exercise duration paralleled the increase in LV passive filling volume (r = 0.85, p < 0.05).
CONCLUSIONS
Nonsurgical septal reduction therapy results in an increase in LV passive filling volume and a reduction in LA size, ejection force and KE.
|
Abbreviations and Acronyms
| | HCM | = hypertrophic cardiomyopathy | | HOCM | = hypertrophic obstructive cardiomyopathy | | KE | = kinetic energy | | LA | = left atrial | | LV | = left ventricular | | LVOT | = left ventricular outflow tract | | MR | = mitral regurgitant | | NSRT | = nonsurgical septal reduction therapy | | NYHA | = New York Heart Association | | RVOT | = right ventricular outflow tract | | TD | = tissue Doppler |
|
This article has been cited by other articles:

|
 |

|
 |
 
S. D. Solomon and L. W. Stevenson
Recalibrating the Barometer: Is It Time to Take a Critical Look at Noninvasive Approaches to Measuring Filling Pressures?
Circulation,
January 6, 2009;
119(1):
13 - 15.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. A. Fifer and G. J. Vlahakes
Management of Symptoms in Hypertrophic Cardiomyopathy
Circulation,
January 22, 2008;
117(3):
429 - 439.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. A. Fifer
Most Fully Informed Patients Choose Septal Ablation Over Septal Myectomy
Circulation,
July 10, 2007;
116(2):
207 - 216.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. F. Nagueh and J. J. Mahmarian
Noninvasive Cardiac Imaging in Patients With Hypertrophic Cardiomyopathy
J. Am. Coll. Cardiol.,
December 19, 2006;
48(12):
2410 - 2422.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. S. Jassal, T. G. Neilan, M. A. Fifer, I. F. Palacios, P. A. Lowry, G. J. Vlahakes, M. H. Picard, and D. M. Yoerger
Sustained improvement in left ventricular diastolic function after alcohol septal ablation for hypertrophic obstructive cardiomyopathy
Eur. Heart J.,
August 1, 2006;
27(15):
1805 - 1810.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Woo, W. G. Williams, R. Choi, E. D. Wigle, E. Rozenblyum, K. Fedwick, S. Siu, A. Ralph-Edwards, and H. Rakowski
Clinical and Echocardiographic Determinants of Long-Term Survival After Surgical Myectomy in Obstructive Hypertrophic Cardiomyopathy
Circulation,
April 26, 2005;
111(16):
2033 - 2041.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. J. Maron, W. J. McKenna, G. K. Danielson, L. J. Kappenberger, H. J. Kuhn, C. E. Seidman, P. M. Shah, W. H. Spencer III, P. Spirito, F. J. Ten Cate, et al.
American College of Cardiology/European Society of Cardiology Clinical Expert Consensus Document on Hypertrophic Cardiomyopathy: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines
J. Am. Coll. Cardiol.,
November 5, 2003;
42(9):
1687 - 1713.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Writing Committee Members, B. J. Maron, W. J. McKenna, G. K. Danielson, L. J. Kappenberger, H. J. Kuhn, C. E. Seidman, P. M. Shah, W. H. Spencer III, P. Spirito, et al.
American College of Cardiology/European Society of Cardiology Clinical Expert Consensus Document on Hypertrophic Cardiomyopathy: A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines
Eur. Heart J.,
November 1, 2003;
24(21):
1965 - 1991.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. S. Bradham Jr, H. Gunasinghe, J. R. Holder, M. Multani, D. Killip, M. Anderson, D. Meyer, W. H. Spencer III, G. Torre-Amione, and F. G. Spinale
Release of matrix metalloproteinases following alcohol septal ablation in hypertrophic obstructive cardiomyopathy
J. Am. Coll. Cardiol.,
December 18, 2002;
40(12):
2165 - 2173.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|